Call for Abstract

24th World Congress on Pediatric Oncology and Cancer Care, will be organized around the theme “{CME-CPD Accreditations Available} Pediatric Cancer and Oncology: Improving Treatments and Fostering Supports”

Pediatric Cancer Congress 2023 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Pediatric Cancer Congress 2023

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.


A specialist nurse who treats cancer patients is known as an oncology nurse. These nurses need higher levels of certification and cancer clinical experience than the normal baccalaureate nursing school can offer. In order to provide oncology patients with the necessary screenings, preventive measures, symptom management, and care to maintain as much normal functioning as possible, and supporting measures towards the end of life, oncology nursing care must be outlined.



Related Conference:  Nursing Oncology Conferences | Nursing Oncology Events | Nursing Oncology Meetings | Nursing Oncology Congress



 



A multidisciplinary approach to treating cancer must include the medical specialty of radiation oncology (radiotherapy/radiotherapy). It makes use of high-energy x-rays (photons), which are typically delivered by a linear accelerator. These non-invasive, painless therapeutic x-rays are used to treat a variety of malignancies. A multidisciplinary team made up of radiation oncologists (your specialist doctor), nurses, radiation therapists, and medical physicists will assess you, plan your treatment, give it to you, and assist you with any side affects you may experience.



Related Conference:  Radiation Oncology Conferences | Radiation Oncology Meetings | Radiation Oncology Congress | Radiation Oncology Events



 



 



Carcinoma of the rectum, which is the bottom portion of the digestive tract. Noncancerous polyps may appear in early cases. These are frequently asymptomatic but can be found by screening. Doctors advise testing for patients at high risk or who are over 50 because of this. The location and size of the disease determine the symptoms of colorectal cancer.



In colorectal cancer, cancer stem cells (CSCs) promote tumour development, metastasis, and treatment resistance (CRC). Because of the intricacy of their isolation, these cells are a prospective target for the treatment of CRC but are challenging to research.



Related Conference:  Colorectal Cancer Conferences | Colorectal Cancer and Stem cells Events | Colorectal Cancer Conference Meetings | Colorectal Cancer Congress



 



Various variables are probably at work, but the precise aetiology of cancer is unknown. Less than 5% of cancers are connected to known hereditary gene mutations, even though genetic factors have been linked to some cancer forms. For instance, BRCA1 and BRCA2 are two genes that have been linked to breast cancer, yet they account for fewer than 5% of all cases of the disease. Most cancers are caused by genetic changes in cells that take place during a person's lifetime as a result of environmental influences like smoking or radiation exposure.



Oncologists, who specialise in treating cancer, will assess your symptoms, examine you physically, and request X-rays and blood testing. But only a tissue sample, known as a biopsy, may be used to determine for sure whether a cell is malignant.



Related Conference:  Pediatric Cancer Diagnosis Conferences | Pediatric Cancer Causes Diagnosis Meetings | Pediatric Cancer Diagnosis Congress | Pediatric Cancer Causes Diagnosis Events



 



Testing for biomarkers is a means to find genes, proteins, and other components (also known as tumor markers or biomarkers) that can reveal information about cancer. A distinct pattern of biomarkers characterizes each person's cancer. Some biomarkers influence the efficacy of specific cancer therapies.



Related Conference:  Cancer Biomarker Conferences | Cancer Biomarker Treatment Meetings | Cancer Biomarker Congress | Cancer Biomarker Events



 



One in every six fatalities worldwide is caused by the global health issue of cancer. The procedure of treating cancer has been quite difficult. Aside from recent significant advancements in stem cell therapy, targeted therapy, ablation therapy, nanoparticles, natural antioxidants, radionics, chemo dynamic therapy, sonodynamic therapy, and ferroptosis-based therapy, traditional treatment modalities like surgery, chemotherapy, and radiotherapy are still in use. Oncology practises today concentrate on creating effective and secure cancer nanomedicines. Targeting both primary and metastatic cancer foci, stem cell therapy has demonstrated remarkable success in regenerating and repairing diseased or damaged tissues, and nanoparticles have introduced novel diagnostic and therapeutic possibilities.



Related Conference:  Pediatric Cancer Diagnosis and Novel approaches Conferences | Pediatric Cancer Diagnosis and Novel approaches Meetings | Pediatric Cancer Diagnosis and Novel approaches Congress | Pediatric Cancer Diagnosis and Novel approaches Events



 



Cancer prevention is the practise of reducing the likelihood of developing cancer. This can involve leading a healthy lifestyle, avoiding contact with known carcinogens, and receiving cancer-preventing treatments or vaccinations. Nearly 1.9 million Americans will receive a cancer diagnosis in 2021. Cancer patients, their families, and the general public are burdened by the high expenditures of care in addition to the physical issues and emotional pain it causes. The number of new cases of cancer is decreased by preventing it. Hopefully, this will lessen the impact of cancer and the number of cancer-related fatalities.



Related Conference:   Cancer Management and Prevention Conferences | Cancer Management and Preventions Conferences meetings | Cancer Management and Prevention Events



 



Ovarian, uterine, vaginal, cervical, and vulvar cancers are among the tumours of the female reproductive system that are the focus of the specialist medical discipline known as Gynaecologic oncology. They have significant training in the detection and management of various tumours as specialists. Every year, 82,000 women in the US receive a gynaecologic cancer diagnosis. An estimated 91,730 people were diagnosed in 2013.



Professional associations for gynaecologic oncologists include the Society of Gynaecologic Oncology, the European Society of Gynaecological Oncology, and the Gynaecologic Oncology Group. These associations serve both gynaecologic oncologists and other medical specialists who treat gynaecologic cancers.



Related Conference: Gynaecologic Oncology Conferences | Gynaecologic Oncology Meetings | Gynaecologic Oncology Congress | Gynaecologic Oncology Events



 



The research and creation of cancer treatments that make use of the immune system of the body are known as immuno-oncology. Our immune system, which is made up of a complex web of organs, cells, and molecules, defends us against pathogenic bacteria, fungi, and viruses as well as other foreign invaders.



Related Conference: Pediatric Immunology Conferences | Pediatric Immunology Meetings | Pediatric Immunology Congress | Pediatric Immunology Events



 



The medical specialty of neurooncology deals with brain and spinal cord malignancies. Nervous system cancers are frequently serious illnesses that can ultimately be fatal.



These neurological cancers can be fatal and include brain stem tumours, astrocytomas, glioblastoma multiform, pontine gliomas, gliomas, and gliomas. High-grade astrocytomas and brain stem gliomas are two of the most serious malignant brain tumours, with patients typically not living more than a few months without therapy.



Related Conference:  Pediatric Neuro Oncology Conferences | Pediatric Neuro Oncology Events | Pediatric Neuro Oncology Meetings | Pediatric Neuro Oncology Congress



 



Chemotherapy, commonly referred to as chemo or anticancer medicine, is the use of drugs to eradicate, eradicate, shrink, or inhibit the proliferation of cancer cells. There are more than 100 distinct chemo medications. While certain malignancies can be treated with only one type of chemotherapy medication, others may require a combination of surgery, radiation, and/or chemotherapy.



Chemotherapy’s primary objective is to:




  • Get rid of cancerous cells


  • minimize the tumor


  • prevent the spread of cancer


  • relieve cancer symptoms



Chemotherapy can be administered via:




  • Intravenous (IV) (IV)


  • Orally (pill or liquid), intravenously


  • cream applied to the skin



Related Conference:   Pediatric Cancer Treatment Conferences | Pediatric Cancer Treatment Meetings | Pediatric Cancer Treatment Congress | Pediatric Cancer Treatment Events



 



The medical specialty that focuses on the analysis, therapy, and management of cancer is known as oncology. Oncologists are medical professionals with a focus in oncology. The field of medicine known as paediatric oncology is dedicated to treating cancer in newborns, kids, and teenagers. A paediatric oncologist is a medical professional who specialises in treating children with cancer.



Related Conference: Pediatric Oncology Conferences | Pediatric Oncology Meetings | Pediatric Oncology Congress | Pediatric Oncology Events | Neonatal Oncology Conferences | Neonatal Oncology Meetings | Neonatal Oncology Congress | Neonatal Oncology Events



 



Lung cancer, which most frequently affects smokers and has its origins in the lungs. Small cell and non-small cell lung cancer are the two main subtypes. Smoking, exposure to second-hand smoke, certain chemicals, and family history are some of the factors that contribute to lung cancer. Chest pain, wheezing, a bloody cough, and weight loss are among the symptoms.



Related Conference: Pulmonary Oncology Conferences | Pulmonary Oncology Events | Pulmonary Oncology Meetings | Pulmonary Oncology Congress



 



A branch of medicine known as surgical oncology focuses on the surgical treatment of cancer. Its major objective is to locate and eliminate any hazardous malignancies from your body. Additionally, surgical oncologists can determine whether you have cancer and whether it has spread to other organs.



Related Conference:  Pediatric Cancer Surgery Conferences | Pediatric Cancer Surgery Meetings | Pediatric Cancer Surgery Congress | Pediatric Cancer Surgery Events



 



A few tests can aid in the early detection of cancer. This process is known as cancer screening. Reduce the number of cancer-related fatalities is one of the primary objectives of cancer screening. Eliminate all cancer-related deaths. A computed tomography (CT) scan, bone scan, magnetic resonance imaging (MRI), positron emission tomography (PET) scan, ultrasound, and X-ray are a few of the imaging procedures that can be used to diagnose cancer. Your doctor takes a sample of cells during a biopsy to examine in a lab.



Related Conference:  Pediatric Cancer Diagnosis Conferences | Pediatric Cancer Diagnosis Meetings | Pediatric Cancer Diagnosis Congress | Pediatric Cancer Diagnosis Events



 



A genetic disorder, malignancy. Changes in the genes that govern how cells divide and grow are the cause of it. The atomic units of your body are cells. Your genes, which function like an instruction manual, are replicated in every cell. DNA segments known as genes contain the information needed to produce one or more proteins. Researchers have identified hundreds of genetic and DNA abnormalities, also known as variants, mutations, or alterations, that support the development, growth, and spread of cancer. Genetic alterations linked to cancer can happen because:




  • As our cells divide, random errors occur in our DNA. Carcinogens in our environment, such as chemicals in cigarette smoke, UV rays from the sun, and the human papillomavirus (HPV), also damage our DNA. These factors were inherited from one of our parents.



Related Conference:  Oncology Genetics Conferences | Oncology Genetics Events | Oncology Genetics Meetings | Oncology Genetics Congress



 



In England and Wales, 50% of those who are diagnosed with cancer go on to have a ten-year or longer survival rate (2010-11).Women has a greater cancer survival rate than males do.



In the UK, cancer survivorship is increasing and has doubled in the past 40 years. In England, Wales, and Scotland, the five-year relative survival rate for cancer in men is lower than the European average. In England, Wales, and Scotland, the five-year relative survival rate for cancer in women is lower than the European average.



The primary objectives of the day are to raise awareness of the illness and reduce the stigma associated with it.



Related Conference:  Pediatric Cancer Survivorship Conferences | Pediatric Cancer Survivorship Meetings | Pediatric Cancer Survivorship Congress | Pediatric Cancer Survivorship Events



 



Cancer epidemiology is the study of the causes of the development, spread, and prognosis of different forms of cancer. Findings from epidemiological studies on cancer can help in the development of effective therapeutic treatment regimens and cancer prevention medications.



Related Conference:  Pediatric Cancer Epidemiology Conferences | Pediatric Cancer Epidemiology Meetings | Pediatric Cancer Epidemiology Congress | Pediatric Cancer Epidemiology Events



 



Metastatic cancer refers to cancer that spreads from the site of origin to a different area of the body. It is also known as stage IV (4) cancer for many different types of cancer. Metastasis is the process through which cancer cells spread to other areas of the body. The primary cancer's term also applies to metastatic cancer. For instance, metastatic breast cancer, not lung cancer, is the term used to describe breast cancer that has spread to the lung. Not lung cancer, but stage IV breast cancer, is how it is handled.



Related Conference: Cancer Metastasis Conferences | Cancer Metastasis Events | Cancer Metastasis Meetings | Cancer Metastasis Congress



 



Radiotherapy and systemic therapy are both used in clinical oncology to treat malignant illness. The majority of cancer patients have many forms of treatment, like surgery to remove a tumour, followed by radiotherapy and/or systemic therapy. A surgical oncologist (or maybe another sort of doctor termed an interventional oncologist) would perform the surgery, and a clinical or medical oncologist and their team would organise and administer the other treatments. Although only clinical oncologists are qualified to provide radiotherapy, both medical oncologists and clinical oncologists provide non-surgical cancer treatment.



Related Conference:  Clinical Oncology Conferences | Clinical Oncology Events | Clinical Oncology Meetings | Clinical Oncology Congress



 



These include:




  • Aromatherapy: Fragrant oils are used in aromatherapy to create a relaxing effect. When receiving a massage or taking a bath, you can apply oils to your skin that have been infused with aromas like lavender. In order to release their scents into the air, fragrant oils can also be heated. Aromatherapy may be helpful in relieving nausea, pain and stress.


  • Cognitive behavioural approach. A popular form of talk therapy is cognitive behavioural therapy (CBT). A mental health professional, such as a psychotherapist or therapist, works with you to view difficult events more clearly and react in a more effective manner during a CBT session.


  • Exercise: Getting some exercise can help you control your symptoms both during and after cancer treatment. You may have less stress and exhaustion as a result of light exercise. Recent research suggests that an exercise regimen may lengthen cancer patients' lives and enhance their general quality of life.



Related Conference:   Pediatric Treatment Cancer Conferences | Pediatric Treatment Cancer Events | Pediatric Treatment Cancer Meetings | Pediatric Treatment Cancer Congress



 



The term "neonatal & paediatric oncology" refers to all cancer-related malignancies that affect newborns & young children. Leukaemia (which starts in blood-forming tissue like bone marrow), lymphoma (cancer in immune system cells), neuroblastoma (cancer of the nerve cells), retinoblastoma (cancer of the tissues of the retina), Wilms tumour (kidney cancer), and brain tumours like gliomas are the most prevalent childhood cancers. Childhood malignancies are extremely uncommon and may behave differently than adult cancers in terms of how they develop, spread, are treated, and react to therapy.



Related Conference:  Pediatric Neonatal Conferences | Pediatric Neonatal Meetings | Pediatric Neonatal Congress | Pediatric Neonatal  Events



 



Studies on cancer explore for to discover more effective ways to identify, diagnose, and treat cancer. These studies can be created in a variety of methods by doctors and scientists to address their research questions. No research plan is ideal. Each has advantages and limitations. It's critical to comprehend the design of studies. This can assist you in interpreting the results for yourself. It will take a while before the findings of certain studies have an impact on patient care because they are very preliminary or "early." The outcomes of other studies could immediately affect how doctors care for and treat cancer patients.



There are 3 main types of cancer research studies:




  • Preclinical studies


  • Experimental studies , called clinical trials


  • Observational study



Related Conference:  Oncology and Cancer Research Conferences | Oncology and Cancer Research Events | Oncology and Cancer Meetings | Oncology and Cancer Congress



 



Pediatric pharmacotherapy is concerned with the special treatment requirements of newborns, babies, kids, and teenagers. Patients in these age groups have unique obstacles that adult patients do not. Medications may not be absorbed, distributed, metabolised, or excreted in the same way as they are in adults, which could result in increased or decreased efficacy or safety.



Related Conference:  Pediatric Pharmacotherapy Conferences | Pediatric Pharmacotherapy Events | Pediatric Pharmacotherapy Meetings | Pediatric Pharmacotherapy Congress